Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists
- PMID: 10565904
- PMCID: PMC85841
- DOI: 10.1128/JCM.37.12.3901-3905.1999
Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists
Abstract
In the present study we compared the clinical presentations of patients with a clinical diagnosis of AIDS and disseminated Mycobacterium genavense infection (n = 12) with those of patients with AIDS and disseminated M. avium complex (MAC) infection (n = 24). Abdominal pain was seen more frequently in the group of patients infected with M. genavense than in patients infected with MAC (P = 0. 003). Analysis of microbiological data revealed that stool specimens from patients infected with M. genavense were more often smear positive than stool specimens from patients infected with MAC (P = 0. 00002). However, M. genavense could be cultured on solid media from only 15.4% of the stool specimens, whereas MAC could be cultured from 71.4% of the specimens. Bone marrow and liver biopsy specimens yielded growth of M. genavense within a reasonably short time, allowing species identification by DNA technology. Microbiological data clearly demonstrated the importance of acidic liquid medium for primary culture, the avoidance of pretreatment and the use of additives in culture, and the necessity for prolonged incubation if M. genavense is suspected. Susceptibility testing showed that M. genavense is sensitive to rifamycins, fluoroquinolones, and macrolides, whereas it is resistant to isoniazid. Susceptibility to ethambutol and clofazimine could not be evaluated. The mean survival times of patients in the two groups were similar.
Similar articles
-
Bias of culture techniques for diagnosing mixed Mycobacterium genavense and Mycobacterium avium infection in AIDS.J Clin Microbiol. 1994 Mar;32(3):828-31. doi: 10.1128/jcm.32.3.828-831.1994. J Clin Microbiol. 1994. PMID: 8195400 Free PMC article.
-
Isolation of nontuberculous, non-avium mycobacteria from patients infected with human immunodeficiency virus.Clin Infect Dis. 1995 Jan;20(1):73-6. doi: 10.1093/clinids/20.1.73. Clin Infect Dis. 1995. PMID: 7727674
-
Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.Arch Intern Med. 1995 Feb 27;155(4):400-4. doi: 10.1001/archinte.1995.00430040074009. Arch Intern Med. 1995. PMID: 7848023
-
Mycobacterium genavense: an emerging pathogen.Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):932-6. doi: 10.1007/BF02111494. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7698119 Review.
-
Disseminated Mycobacterium genavense infection in two patients with AIDS.Clin Infect Dis. 1994 Mar;18(3):455-7. doi: 10.1093/clinids/18.3.455. Clin Infect Dis. 1994. PMID: 7516719 Review.
Cited by
-
Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2.J Clin Microbiol. 2004 Sep;42(9):4403-4. doi: 10.1128/JCM.42.9.4403-4404.2004. J Clin Microbiol. 2004. PMID: 15365056 Free PMC article.
-
Persistence of nontuberculous mycobacteria in a drinking water system after addition of filtration treatment.Appl Environ Microbiol. 2006 Sep;72(9):5864-9. doi: 10.1128/AEM.00759-06. Appl Environ Microbiol. 2006. PMID: 16957205 Free PMC article.
-
Mycobacterium genavense Infections in a Tertiary Hospital and Reviewed Cases in Non-HIV Patients.Patholog Res Int. 2014;2014:371370. doi: 10.1155/2014/371370. Epub 2014 Feb 19. Patholog Res Int. 2014. PMID: 24693456 Free PMC article.
-
Infection with Mycobacterium genavense in a patient with systemic lupus erythematosus.Clin Rheumatol. 2009 Jun;28 Suppl 1:S39-41. doi: 10.1007/s10067-009-1120-4. Epub 2009 Feb 28. Clin Rheumatol. 2009. PMID: 19252819
-
The Underestimated Threat-Mycobacterium Genavense Infection: A Case Report.Infect Dis Rep. 2025 Jun 1;17(3):60. doi: 10.3390/idr17030060. Infect Dis Rep. 2025. PMID: 40559191 Free PMC article.
References
-
- Bessesen M T, Shlay J, Stone Venohr B, Cohn D L, Reves R R. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS. 1993;7:1357–1361. - PubMed
-
- Böttger E C, Hirschel B, Coyle M B. Mycobacterium genavense sp. nov. Int J Syst Bacteriol. 1993;43:841–843. - PubMed
-
- Böttger E C, Teske A, Kirschner P, Bost S, Chang H R, Beer V, Hirschel B. Disseminated “Mycobacterium genavense” infection in patients with AIDS. Lancet. 1992;340:76–80. - PubMed
-
- Department of Epidemiology, Statens Serum Institut. AIDS surveillance, quarterly report June 30. EPI-NEWS, week 37. Copenhagen, Denmark: Department of Epidemiology, Statens Serum Institut; 1995.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical